1.50 cme credits cytomegalovirus in the transplantation ...… · why: earn up to 1.50 cme credits...
TRANSCRIPT
6900 Grove Road • Building 100Thorofare, NJ 08086-9447
VINDICOmedical education
PresortedFirst Class Mail
US PostagePAID
Permit # 906Bellmawr NJ
Friday, October 23, 2020 7:00 pm – 8:30 pm ET Virtual Satellite Symposium with LIVE Question and Answer held during IDWeekTM 2020
FAcuLty Roy F. Chemaly, MD, MPH, FIDSA, FACPGenovefa A. Papanicolaou, MD, FIDSA
ActIVIty chAIr Francisco M. Marty, MD, FIDSA
This activity is supported by an educational grantfrom Merck & Co., Inc.
This activity is not affiliated with the official program of IDWeekTM 2020.
This continuing medical education activity is provided by
Cytomegalovirus in the Transplantation Setting Assessing the Evidence
in real-world Applications
You’re invited...What: Cytomegalovirus in the
Transplantation Setting: Assessing the Evidence in Real-world Applications
When: Friday, October 23, 20207:00 pm – 8:30 pm ETVirtual Satellite Symposium With LIVE Question and Answer
Why: Earn up to 1.50 CME credits
How: Access within the Affiliated Event Theater on the IDWeekTM
2020 Virtual Platform
1.50 CME CREDITS
AgEnDAIntroductionFrancisco M. Marty, MD, FIDSA
CMV in the Transplant Setting: An Ongoing DilemmaGenovefa A. Papanicolaou, MD, FIDSA
CMV Mitigation: Current StatusRoy F. Chemaly, MD, MPH, FIDSA, FACP
Case Discussion: Secondary CMV Prophylaxis in HSCT Patient Who Experienced Adverse Effects From Anti-CMV AntiviralsRoy F. Chemaly, MD, MPH, FIDSA, FACP
CMV: Controversies in ManagementFrancisco M. Marty, MD, FIDSA
Case Discussion: Solid Organ Transplant Patient With CMV ReactivationGenovefa A. Papanicolaou, MD, FIDSA
LIVE Question and Answer
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of accredited content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be mitigated and disclosed to the activity audience.
Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from the Program Director and the Office of Medical Affairs and Compliance.
© 2020 iStockphoto.com/sturti; Ali Shahgholi K261
OVErVIEwIn this CME webinar, expert clinicians will discuss incorporating recent evidence into practice regarding the use of prophylactic and preemptive measures for cytomegalovirus (CMV) disease. They will compare conventional versus newer antiviral therapies in terms of safety and efficacy, ability to reduce CMV reactivation, and improvement of survival in transplant recipients. They will also evaluate the optimal duration of prophylactic or preemptive treatment in patients at risk for CMV reactivation.
LEArnIng ObjEctIVESUpon successful completion of this activity, participants should be better able to:• Incorporate recent evidence into practice regarding the use of prophylactic and
preemptive measures to prevent CMV disease in transplant recipients.• Differentiate conventional versus newer antiviral therapies in terms of safety
and efficacy, ability to reduce CMV reactivation, and improvement of survival in transplant recipients.
• Evaluate the optimal duration of prophylactic or preemptive treatment in patients at risk for CMV reactivation.
tArgEt AuDIEncEThe intended audience for this activity is infectious disease specialists and other health care professionals involved in the management of patients with CMV.
FAcuLty Roy F. Chemaly, MD, MPH, FIDSA, FACPProfessor of MedicineDirector, Clinical Virology ResearchDirector, Infection Control SectionDepartment of ID/IC/EHUT MD Anderson Cancer CenterProfessor, Division of Epidemiology, Human Genetics, and Environmental SciencesUT School of Public HealthAdjunct-Professor of MedicineBaylor College of MedicineHouston, TX
Genovefa A. Papanicolaou, MD, FIDSAAttending Physician, Infectious Disease Service Memorial Sloan Kettering Cancer CenterNew York, NY
ActIVIty chAIr Francisco M. Marty, MD, FIDSAAssociate Professor of MedicineHarvard Medical SchoolAssociate Physician, Brigham and Women’s HospitalStaff Physician, Dana-Farber Cancer InstituteBoston, MA
Access within the Affiliated Event Theater on the IDWeekTM 2020 Virtual Platform [email protected]
6900 Grove Road • Building 100Thorofare, NJ 08086-9447
VINDICOmedical education
PresortedFirst Class Mail
US PostagePAID
Permit # 906Bellmawr NJ
Friday, October 23, 2020 7:00 pm – 8:30 pm ET Virtual Satellite Symposium with LIVE Question and Answer held during IDWeekTM 2020
FAcuLty Roy F. Chemaly, MD, MPH, FIDSA, FACPGenovefa A. Papanicolaou, MD, FIDSA
ActIVIty chAIr Francisco M. Marty, MD, FIDSA
This activity is supported by an educational grantfrom Merck & Co., Inc.
This activity is not affiliated with the official program of IDWeekTM 2020.
This continuing medical education activity is provided by
Cytomegalovirus in the Transplantation Setting Assessing the Evidence
in real-world Applications
You’re invited...What: Cytomegalovirus in the
Transplantation Setting: Assessing the Evidence in Real-world Applications
When: Friday, October 23, 20207:00 pm – 8:30 pm ETVirtual Satellite Symposium With LIVE Question and Answer
Why: Earn up to 1.50 CME credits
How: Access within the Affiliated Event Theater on the IDWeekTM
2020 Virtual Platform
1.50 CME CREDITS